TABLE 3.
Treatment 4d | Adrb3 | SEM | Ucp1 | SEM | Tbx1 | SEM | Trpv1 | SEM | Prdm16 | SEM | Ppargc1a | SEM | Cidec | SEM | Cidea | SEM | Plin1 | SEM | |||||||||
NE | 8.70A | ± | 1.24 | 3.34A | ± | 0.45 | 2.10 | ± | 0.33 | 1.57 | ± | 0.39 | 3.04 | ± | 0.64 | 2.16AB | ± | 0.50 | 1.90 | ± | 0.28 | 1.34 | ± | 0.22 | 1.64 | ± | 0.35 |
1CP | 0.66B | ± | 1.25 | 0.94AB | ± | 0.45 | 0.92 | ± | 0.33 | 1.16 | ± | 0.40 | 0.95 | ± | 0.65 | 4.07A | ± | 0.51 | 1.38 | ± | 0.28 | 1.12 | ± | 0.23 | 0.22 | ± | 0.36 |
0.1CPNE | 3.04AB | ± | 1.53 | 2.12AB | ± | 0.55 | 0.81 | ± | 0.41 | 1.28 | ± | 0.49 | 1.66 | ± | 0.79 | 1.86AB | ± | 0.62 | 0.56 | ± | 0.35 | 0.87 | ± | 0.28 | 0.08 | ± | 0.44 |
CTRL | 0.96B | ± | 1.25 | 0.95AB | ± | 0.45 | 1.03 | ± | 0.33 | 1.15 | ± | 0.40 | 1.04 | ± | 0.65 | 1.18B | ± | 0.51 | 1.00 | ± | 0.28 | 1.13 | ± | 0.23 | 1.15 | ± | 0.36 |
0.1CP | 0.64B | ± | 1.25 | 0.52B | ± | 0.45 | 0.71 | ± | 0.33 | 0.73 | ± | 0.40 | 0.84 | ± | 0.65 | 2.79AB | ± | 0.51 | 1.25 | ± | 0.28 | 1.37 | ± | 0.23 | 0.42 | ± | 0.36 |
1CPNE | 2.44AB | ± | 1.25 | 0.93AB | ± | 0.45 | 0.69 | ± | 0.33 | 1.12 | ± | 0.40 | 2.69 | ± | 0.65 | 1.68AB | ± | 0.51 | 0.44 | ± | 0.28 | 0.74 | ± | 0.23 | 0.09 | ± | 0.36 |
Pr > F (Model) | 0.007 | 0.018 | 0.088 | 0.790 | 0.136 | 0.029 | 0.039 | 0.383 | 0.064 | ||||||||||||||||||
Treatment 8d | Adrb3 | SEM | Ucp1 | SEM | Tbx1 | SEM | Trpv1 | SEM | Prdm16 | SEM | Ppargc1a | SEM | Cidec | SEM | Cidea | SEM | Plin1 | SEM | |||||||||
CTRL | 1.00A | ± | 0.07 | 0.66B | ± | 0.52 | 1.05 | ± | 0.12 | 1.06 | ± | 0.26 | 0.78B | ± | 0.33 | 1.02 | ± | 0.14 | 1.02ABC | ± | 0.17 | 1.03AB | ± | 0.18 | 0.92A | ± | 0.13 |
NE | 0.16B | ± | 0.07 | 3.59A | ± | 0.50 | 0.92 | ± | 0.12 | 1.62 | ± | 0.26 | 2.83A | ± | 0.33 | 0.95 | ± | 0.14 | 0.60BC | ± | 0.17 | 0.50B | ± | 0.18 | 0.35AB | ± | 0.12 |
1CP | 0.78A | ± | 0.07 | 1.11AB | ± | 0.52 | 0.72 | ± | 0.12 | 0.99 | ± | 0.26 | 0.82B | ± | 0.33 | 0.76 | ± | 0.14 | 1.32AB | ± | 0.17 | 0.57B | ± | 0.18 | 0.66AB | ± | 0.13 |
0.1CP | 0.96A | ± | 0.07 | 0.66B | ± | 0.52 | 0.58 | ± | 0.12 | 0.74 | ± | 0.26 | 0.56B | ± | 0.33 | 0.90 | ± | 0.14 | 1.87A | ± | 0.17 | 1.89A | ± | 0.18 | 0.85A | ± | 0.13 |
0.1CPNE | 0.14B | ± | 0.07 | 1.60AB | ± | 0.52 | 0.60 | ± | 0.12 | 0.74 | ± | 0.26 | 0.84B | ± | 0.33 | 0.44 | ± | 0.14 | 1.04ABC | ± | 0.17 | 0.27B | ± | 0.18 | 0.37AB | ± | 0.13 |
1CPNE | 0.09B | ± | 0.07 | 2.15AB | ± | 0.52 | 0.58 | ± | 0.12 | 1.52 | ± | 0.26 | 2.09AB | ± | 0.33 | 0.58 | ± | 0.14 | 0.24C | ± | 0.17 | 0.12B | ± | 0.18 | 0.10B | ± | 0.13 |
Pr > F (Model) | <0.0001 | 0.015 | 0.072 | 0.125 | 0.002 | 0.088 | 0.000 | 0.000 | 0.005 |
CTRL = vehicle negative control; NE = 10 μM norepinephrine; 0.1CP = 0.1 μM capsaicin; 0.1CPNE = 0.1 μM capsaicin plus 10 μM norepinephrine; 1CP = 1 μM capsaicin; 1CPNE = 1 μM capsaicin plus 10 μM norepinephrine. Adrb3, adrenoceptor beta 3; Ucp1, uncoupling protein 1; Tbx1, T-box 1;Trpv1, transient receptor potential vanilloid 1; Prdm16, proline rich domain containing 16; Ppargc1a, peroxisome proliferator-activated receptor γ coactivator 1 α; Cidec, cell death inducing DFFA like effector C; Cidea, cell death-inducing DFFA-like effector A; Plin1, perilipin 1. 4d = at 4 days of differentiation; 8d = at 8 days of differentiation. The data are shown as Least squares (LS) means ± standard error of the mean (SEM). Pr > F (Model) = p-value for the effect of the model on the response. Capital letters indicate a significant Bonferroni-corrected difference (p < 0.003).